KRAS and colorectal carcinoma: Besides the modest-moderate frequency of KRAS mutations in human serrated CRCs, the low overall frequency of PTEN mutations in human primary CRCs raises some questions about the relevance of mouse models combining Kras activation and Pten inactivation to model serrated CRC.